Literature DB >> 33443705

The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer.

Janet Hardy1, Mellar P Davis2.   

Abstract

OPINION STATEMENT: In cancer patients, the management of nausea and vomiting that is not directly related to treatment is challenging. Much current practice is based on expert opinion and anecdote. Fortunately, over recent years, a number of quality trials have been undertaken to strengthen the evidence base that guides the care of our patients with these distressing symptoms. Much is still unknown however. In this article, we present the latest literature that addresses some of the outstanding issues.

Entities:  

Keywords:  Cancer; Nausea; Palliative care; Vomiting

Mesh：

Substances：

Year:  2021        PMID： 33443705     DOI： 10.1007/s11864-020-00813-0

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  70 in total

1.  Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro.

Authors:  F P Bymaster; D L Nelson; N W DeLapp; J F Falcone; K Eckols; L L Truex; M M Foreman; V L Lucaites; D O Calligaro
Journal:  Schizophr Res       Date:  1999-05-04       Impact factor: 4.939

Review 2.  Treatment of nausea and vomiting in advanced cancer.

Authors:  M P Davis; D Walsh
Journal:  Support Care Cancer       Date:  2000-11       Impact factor: 3.603

3.  Tropisetron versus Metoclopramide in the Control of Emesis in Far-Advanced Cancer.

Authors: 
Journal:  Oncologist       Date:  1997

Review 4.  Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.

Authors:  S N Ghaemi; F K Goodwin
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153

5.  Nausea and vomiting in advanced cancer.

Authors:  Sik Kim Ang; Laura K Shoemaker; Mellar P Davis
Journal:  Am J Hosp Palliat Care       Date:  2010-03-02       Impact factor: 2.500

6.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

Authors:  R S Keefe; S G Silva; D O Perkins; J A Lieberman
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

Review 7.  Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.

Authors:  Paul Glare; Glenn Pereira; Linda J Kristjanson; Martin Stockler; Martin Tattersall
Journal:  Support Care Cancer       Date:  2004-04-24       Impact factor: 3.603

8.  Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE).

Authors:  H L McCabe; A Maraveyas
Journal:  Anticancer Res       Date:  2003 Nov-Dec       Impact factor: 2.480

9.  Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial.

Authors:  Janet Rea Hardy; Helen Skerman; Jennifer Philip; Phillip Good; David C Currow; Geoffrey Mitchell; Patsy Yates
Journal:  BMJ Open       Date:  2019-09-12       Impact factor: 2.692

10.  Evidence for the use of Levomepromazine for symptom control in the palliative care setting: a systematic review.

Authors:  Isabel Dietz; Andrea Schmitz; Ingrid Lampey; Christian Schulz
Journal:  BMC Palliat Care       Date:  2013-01-19       Impact factor: 3.234
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.